Evidence map›Paper›PMID 30018119›Full record

ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers.

Vivek Subbiah, Ravi Murthy, David S Hong, Robert M Prins, Chitra Hosing, Kyle Hendricks, Deepthi Kolli, Lori Noffsinger, Robert Brown, Mary McGuire and 7 more

Open access · bronzeAbstract readClinical Trial, Phase IMulticenter Study
In one paragraph

Article in Clinical cancer research : an official journal of the American Association for Cancer Research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Acetic Acid and Iodine Staining for Determining Malignancy in Solid Tumors.Asian Pacific journal of cancer prevention : APJCP · 2021
    Article
  12. Review
  13. (Im)maturity in Tumor Ecosystem.Frontiers in oncology · 2021
    Review
  14. Dendritic cell biology and its role in tumor immunotherapy.Journal of hematology & oncology · 2020
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Vivek Subbiah *Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. vsubbiah@mdanderson.org.
Ravi Murthy *Department of Interventional Radiology, Division of Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
David S HongDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Robert M PrinsDepartment of Neurosurgery, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.
Chitra HosingDepartment of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Kyle HendricksCognate Bioservices, Memphis, Tennessee.
Deepthi KolliCognate Bioservices, Memphis, Tennessee.
Lori NoffsingerCognate Bioservices, Memphis, Tennessee.
Robert BrownDepartment of Pathology and Laboratory Medicine, UT Health, University of Texas Health Science Center, Houston, Texas.
Mary McGuireDepartment of Pathology and Laboratory Medicine, UT Health, University of Texas Health Science Center, Houston, Texas.ORCID 0000-0002-4028-8112
Siquing FuDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Sarina Piha-PaulDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Aung NaingDepartment of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Anthony P ConleyDepartment of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Robert S BenjaminDepartment of Sarcoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Indreshpal KaurCell Therapy Labs, GMP Laboratory, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Marnix L BoschNorthwest Biotherapeutics, Inc., Bethesda, Maryland.
The University of Texas MD Anderson Cancer Center · USFisher Bioservices (United States) · USThe University of Texas Health Science Center · USNorthwest Biotherapeutics (United States) · USUniversity of California, Los Angeles · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
UCLA SPORE in Brain CancerP50CA211015 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Yvonne Yu-Hsuan Chen · 2017 to 2026
$25.2M
NCI NIH HHS P30 CA016672NCI NIH HHS P50 CA211015
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell- and Tissue-Based TherapyImmunotherapyAdultAgedCytokinesDendritic CellsFemaleHumansInjections, IntralesionalInterleukin-12Interleukin-8MaleMiddle AgedNeoplasmsTumor MicroenvironmentCytokinesInterleukin-12Interleukin-8

Identifiers

PMID30018119
PMCPMC6449174
OpenAlexW2884013855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.